{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T07:59:21Z","timestamp":1765007961787,"version":"3.46.0"},"reference-count":34,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2021,4,6]]},"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Actinic keratosis (AK) is a precursor of cutaneous squamous cell carcinoma (SCC). No validated parameters can predict which AKs will progress into SCCs, but especially thick AKs are under suspicion. The clinical and histopathological thickness of AKs is strongly correlated. This study aimed to investigate the thicknesses and degree of dysplasia of AKs contiguous with SCCs assuming these AKs represent the AKs that have undergone malignant transformation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Files of the Pathology Department, Hospital of Southern Jutland, Denmark, were reviewed. 111 cases met the inclusion criteria: a skin biopsy containing an invasive SCC. All SCCs merged with an AK at the edge. Degree of dysplasia, epidermal thickness and stratum corneum thicknesses of AKs were measured.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>All AKs showed severe dysplasia. Most AKs had a stratum corneum thickness under 0.1\u2009mm and an epidermal thickness under 0.5\u2009mm, corresponding to clinically thin and non-hyperkeratotic AKs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our result suggests malignant progression potential of AKs regardless of thickness.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jclinpath-2021-207497","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T13:45:47Z","timestamp":1618580747000},"page":"560-563","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Actinic keratoses contiguous with squamous cell carcinomas are mostly non-hyperkeratotic and with severe dysplasia"],"prefix":"10.1136","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6130-875X","authenticated-orcid":false,"given":"Ida M","family":"Heerfordt","sequence":"first","affiliation":[{"name":"Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Poulsen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital of Southern Jutland, Soenderborg, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Christian","family":"Wulf","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,4,16]]},"reference":[{"key":"2025120523560210000_75.8.560.1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI57415"},{"key":"2025120523560210000_75.8.560.2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1998.00467.x"},{"key":"2025120523560210000_75.8.560.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70119-2"},{"key":"2025120523560210000_75.8.560.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2006.32228.x"},{"key":"2025120523560210000_75.8.560.5","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.103342"},{"key":"2025120523560210000_75.8.560.6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/jdv.12102","article-title":"Prevalence and risk factors of actinic keratoses in Germany--analysis of multisource data","volume":"28","author":"Schaefer","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025120523560210000_75.8.560.7","doi-asserted-by":"crossref","unstructured":"Gupta AK , Paquet M , Villanueva E , et al . Interventions for actinic keratoses. Cochrane Database Syst Rev;12.doi:10.1002\/14651858.CD004415.pub2","DOI":"10.1002\/14651858.CD004415.pub2"},{"key":"2025120523560210000_75.8.560.8","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/jdv.13626","article-title":"Actinic keratosis: correlation between clinical and histological classification systems","volume":"30","author":"Schmitz","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025120523560210000_75.8.560.9","doi-asserted-by":"crossref","DOI":"10.1038\/srep33952","article-title":"Thickness of actinic keratosis does not predict dysplasia severity or p53 expression","volume":"6","author":"Heerfordt","year":"2016","journal-title":"Sci Rep"},{"key":"2025120523560210000_75.8.560.10","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(88)91658-3"},{"key":"2025120523560210000_75.8.560.11","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1067\/mjd.2000.103339","article-title":"The risk of progression to invasive disease","volume":"42","author":"Glogau","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"2025120523560210000_75.8.560.12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/00128071-200405030-00001","article-title":"Quantifying actinic keratosis: assessing the evidence","volume":"5","author":"Epstein","year":"2004","journal-title":"Am J Clin Dermatol"},{"key":"2025120523560210000_75.8.560.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07692.x"},{"key":"2025120523560210000_75.8.560.14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/jdv.16680","article-title":"Histopathological predictor of the progression from actinic keratosis to squamous cell carcinoma: quantitative computer-aided image analysis","volume":"35","author":"Lee","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025120523560210000_75.8.560.15","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/jdv.15649","article-title":"Actinic keratoses: what classification is useful to predict the risk of progression? pros and cons","volume":"33","author":"Rongioletti","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025120523560210000_75.8.560.16","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1067\/mjd.2000.103344","article-title":"Histopathology of incipient intraepidermal squamous cell carcinoma (\"actinic keratosis\")","volume":"42","author":"Cockerell","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"2025120523560210000_75.8.560.17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2133.2007.07860.x","article-title":"Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification","volume":"156 Suppl 3","author":"R\u00f6wert-Huber","year":"2007","journal-title":"Br J Dermatol"},{"key":"2025120523560210000_75.8.560.18","doi-asserted-by":"publisher","DOI":"10.1080\/00015550310015419"},{"key":"2025120523560210000_75.8.560.19","doi-asserted-by":"publisher","DOI":"10.1007\/s004030050453"},{"key":"2025120523560210000_75.8.560.20","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12848"},{"key":"2025120523560210000_75.8.560.21","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/bjd.16536","article-title":"Cutaneous squamous cell carcinomas are associated with basal proliferating actinic keratoses","volume":"180","author":"Schmitz","year":"2019","journal-title":"Br J Dermatol"},{"key":"2025120523560210000_75.8.560.22","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/bjd.14498","article-title":"A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(\u00ae)) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(\u00ae) lamp","volume":"175","author":"Reinhold","year":"2016","journal-title":"Br J Dermatol"},{"key":"2025120523560210000_75.8.560.23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/09546634.2016.1254328","article-title":"Real-World approach to actinic keratosis management: practical treatment algorithm for office-based dermatology","volume":"28","author":"Dirschka","year":"2017","journal-title":"J Dermatolog Treat"},{"key":"2025120523560210000_75.8.560.24","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/bjd.15304","article-title":"A seamless phase I\/II dose-finding trial assessing ingenol disoxate (Leo 43204) for field treatment of actinic keratosis on the scalp","volume":"176","author":"Weiss","year":"2017","journal-title":"Br J Dermatol"},{"key":"2025120523560210000_75.8.560.25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pdpdt.2016.08.005","article-title":"A randomized split-face clinical trial analyzing daylight photodynamic therapy with methyl aminolaevulinate vs ingenol mebutate gel for the treatment of multiple actinic keratoses of the face and the scalp","volume":"16","author":"Moggio","year":"2016","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"2025120523560210000_75.8.560.26","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1177\/1203475417702994","article-title":"Structured expert consensus on actinic keratosis: treatment algorithm focusing on daylight PDT","volume":"21","author":"Calzavara-Pinton","year":"2017","journal-title":"J Cutan Med Surg"},{"key":"2025120523560210000_75.8.560.27","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/bjd.15098","article-title":"Increased protoporphyrin IX accumulation does not improve the effect of photodynamic therapy for actinic keratosis: a randomized controlled trial","volume":"176","author":"Nissen","year":"2017","journal-title":"Br J Dermatol"},{"key":"2025120523560210000_75.8.560.28","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2340\/00015555-2612","article-title":"Pretreatment with 5-fluorouracil cream enhances the efficacy of Daylight-mediated photodynamic therapy for actinic keratosis","volume":"97","author":"Nissen","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"2025120523560210000_75.8.560.29","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1600-0781.2011.00611.x","article-title":"Continuous ultra-low-intensity artificial daylight is not as effective as red led light in photodynamic therapy of multiple actinic keratoses","volume":"27","author":"Wiegell","year":"2011","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2025120523560210000_75.8.560.30","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/jdv.15744","article-title":"Daylight photodynamic therapy of actinic keratosis without curettage is as effective as with curettage: a randomized clinical trial","volume":"33","author":"Heerfordt","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025120523560210000_75.8.560.31","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/bjd.14465","article-title":"Pulse photodynamic therapy reduces inflammation without compromising efficacy in the treatment of multiple mild actinic keratoses of the face and scalp: a randomized clinical trial","volume":"174","author":"Wiegell","year":"2016","journal-title":"Br J Dermatol"},{"key":"2025120523560210000_75.8.560.32","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1365-2133.2009.09119.x","article-title":"Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial","volume":"160","author":"Wiegell","year":"2009","journal-title":"Br J Dermatol"},{"key":"2025120523560210000_75.8.560.33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ced.13222","article-title":"Invasive squamous cell carcinoma: comparison of differentiation grade and tumour depth by anatomical site in 1666 tumours","volume":"43","author":"Pyne","year":"2018","journal-title":"Clin Exp Dermatol"},{"key":"2025120523560210000_75.8.560.34","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70178-5"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jclinpath-2021-207497","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T07:56:10Z","timestamp":1765007770000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jclinpath-2021-207497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,16]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,7,19]]},"published-print":{"date-parts":[[2022,8]]}},"alternative-id":["10.1136\/jclinpath-2021-207497"],"URL":"https:\/\/doi.org\/10.1136\/jclinpath-2021-207497","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"type":"print","value":"0021-9746"},{"type":"electronic","value":"1472-4146"}],"subject":[],"published":{"date-parts":[[2021,4,16]]}}}